Mathematical modelling and experimental validation of a novel periodic flow crystallization using MSMPR crystallizers
暂无分享,去创建一个
Zoltan K. Nagy | Qinglin Su | Chris D. Rielly | Keddon A. Powell | Z. Nagy | C. Rielly | Q. Su | K. Powell
[1] Richard D. Braatz,et al. Modification of Crystal Shape through Deep Temperature Cycling , 2014 .
[2] Mark Kessel,et al. The problems with today's pharmaceutical business—an outsider's view , 2011, Nature Biotechnology.
[3] P. Frawley,et al. Computational Fluid Dynamics Analysis of the Suspension of Nonspherical Particles in a Stirred Tank , 2011 .
[4] Z. Nagy,et al. Determination of the Kinetic Parameters for the Crystallization of Paracetamol from Water Using Metastable Zone Width Experiments , 2008 .
[5] R. Braatz,et al. Continuous-Flow Tubular Crystallization in Slugs Spontaneously Induced by Hydrodynamics , 2014 .
[6] Niall A. Mitchell,et al. Nucleation kinetics of paracetamol-ethanol solutions from induction time experiments using Lasentec FBRM® , 2011 .
[7] Adel F. Sarofim,et al. Models of secondary nucleation attributable to crystal‐crystallizer and crystal‐crystal collisions , 1974 .
[8] António A. Vicente,et al. Residence times and mixing of a novel continuous oscillatory flow screening reactor , 2004 .
[9] William R. Paterson,et al. Orthokinetic Aggregation During Precipitation: A Computational Model for Calcium Oxalate Monohydrate , 1997 .
[10] Allan S. Myerson,et al. Crystallization of Cyclosporine in a Multistage Continuous MSMPR Crystallizer , 2011 .
[11] Allan S. Myerson,et al. Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .
[12] Christopher L. Burcham,et al. Regions of attainable particle sizes in continuous and batch crystallization processes , 2014 .
[13] Stefan Radl,et al. Continuously Seeded, Continuously Operated Tubular Crystallizer for the Production of Active Pharmaceutical Ingredients , 2010 .
[14] Zoltan K. Nagy,et al. Pharmaceutical crystallisation processes from batch to continuous operation using MSMPR stages: Modelling, design, and control , 2015 .
[15] Zoltan K. Nagy,et al. Periodic steady-state flow crystallization of a pharmaceutical drug using MSMPR operation , 2015 .
[16] António A. Vicente,et al. Liquid backmixing in oscillatory flow through a periodically constricted meso-tube , 2010 .
[17] Duncan A. Mellichamp,et al. Reducing the mean size of API crystals by continuous manufacturing with product classification and recycle , 2010 .
[18] Zoltan K. Nagy,et al. Population balance model based multi-objective optimization and robustness analysis of a continuous plug flow antisolvent crystallizer , 2014, 2014 American Control Conference.
[19] Patrick J. Frawley,et al. Estimation of the growth kinetics for the cooling crystallisation of paracetamol and ethanol solutions , 2011 .
[20] Zoltan K. Nagy,et al. Fines removal in a continuous plug flow crystallizer by optimal spatial temperature profiles with controlled dissolution , 2013 .
[21] Yang Yang,et al. Advanced control approaches for combined cooling/antisolvent crystallization in continuous mixed suspension mixed product removal cascade crystallizers , 2015 .
[22] S. Y. Wong,et al. Development of Continuous Crystallization Processes Using a Single-Stage Mixed-Suspension, Mixed-Product Removal Crystallizer with Recycle , 2012 .
[23] Panagiotis D. Christofides,et al. Crystal shape and size control using a plug flow crystallization configuration , 2014 .
[24] Patrick J. Frawley,et al. Nucleation kinetics of paracetamol–ethanol solutions from metastable zone widths , 2010 .
[25] Allan S. Myerson,et al. Development of Continuous Anti-Solvent/Cooling Crystallization Process using Cascaded Mixed Suspension, Mixed Product Removal Crystallizers , 2012 .
[26] Richard D. Braatz,et al. Modeling and Bayesian parameter estimation for semibatch pH‐shift reactive crystallization of l‐glutamic acid , 2014 .
[27] H Leuenberger,et al. New trends in the production of pharmaceutical granules: batch versus continuous processing. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] Panagiotis D. Christofides,et al. Enhancing the Crystal Production Rate and Reducing Polydispersity in Continuous Protein Crystallization , 2014 .
[29] Sigurd Buchholz,et al. Future manufacturing approaches in the chemical and pharmaceutical industry , 2010 .
[30] Yang Yang,et al. Combined Cooling and Antisolvent Crystallization in Continuous Mixed Suspension, Mixed Product Removal Cascade Crystallizers: Steady-State and Startup Optimization , 2015 .
[31] Brahim Benyahia,et al. Mathematical Modeling, Design, and Optimization of a Multisegment Multiaddition Plug-Flow Crystallizer for Antisolvent Crystallizations , 2015 .
[32] Gerry Steele,et al. Continuous Crystallization of Pharmaceuticals Using a Continuous Oscillatory Baffled Crystallizer , 2009 .
[33] Zoltan K. Nagy,et al. Prediction and control of crystal shape distribution in the presence of crystal growth modifiers , 2013 .